My HPRA: Register

PADVIRAM

600/200/245 Milligram Film Coated Tablet

Rowex LtdPA0711/277/001

Main Information

Trade NamePADVIRAM
Active SubstancesEFAVIRENZ
EMTRICITABINE
TENOFOVIR DISOPROXIL SUCCINATE
Strength600/200/245 Milligram
Dosage FormFilm Coated Tablet
Licence HolderRowex Ltd
Licence NumberPA0711/277/001

Group Information

ATC CodeJ05AR06 Antivirals for treatment of HIV infections, combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued20/10/2017
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusNot Marketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.